A Financial Times opinion piece says the health technology company needs more than celebrity endorsements to justify its valuation.
The Financial Times argues that Oura will struggle to justify its $16 billion valuation. The opinion piece says the health technology company needs more than celebrity endorsements.
28.6K
1 post, first seen 3h ago
A Financial Times opinion piece says the health technology company needs more than celebrity endorsements to justify its valuation.
The Financial Times argues that Oura will struggle to justify its $16 billion valuation. The opinion piece says the health technology company needs more than celebrity endorsements.
Financial Times@FTOura will struggle to justify pulse-racing $16bn valuation https://ft.trib.al/4hxYsYA | opinion
Financial Times@FTOura will struggle to justify pulse-racing $16bn valuation https://ft.trib.al/4hxYsYA | opinion
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet
Tech